Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial

Thread starter U.S. News
Start date Dec 11, 2025

U.S. News

Guest

Dec 11, 2025

The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial

Prefix: N/A

Forum: USA News

Start date: Dec 11, 2025

Last reply date: Dec 11, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Dec 11, 2025

Replies: 0

Views: 3

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search